Drug Type TCR therapy |
Synonyms GB 3010, GB-3010 |
Target |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 1 | CN | 07 Sep 2021 | |
Pancreatic Carcinoma | Preclinical | - | - |